News2022-02-18T12:03:25+00:00

News & Events

News & Events

News
& Events

Upcoming Events

News

Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2

By |October 23rd, 2023|Categories: News|

Study is designed to evaluate the safety and tolerability of

Comments Off on Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2

All News & Events

Case studies

Go to Top